The arousing and motor-activating effects of psychostimulants are mediated by multiple systems. In Drosophila, dopaminergic transmission is involved in mediating the arousing effects of methamphetamine, although the neuronal mechanisms of caffeine (CAFF)-induced wakefulness remain unexplored. Here, we show that in Drosophila, as in mammals, the wake-promoting effect of CAFF involves both the adenosinergic and dopaminergic systems. By measuring behavioral responses in mutant and transgenic flies exposed to different drug-feeding regimens, we show that CAFFinduced wakefulness requires the Drosophila D1 dopamine receptor (dDA1) in the mushroom bodies. In WT flies, CAFF exposure leads to downregulation of dDA1 expression, whereas the transgenic overexpression of dDA1 leads to CAFF resistance. The wakepromoting effects of methamphetamine require a functional dopamine transporter as well as the dDA1, and they engage brain areas in addition to the mushroom bodies.
The arousing and motor-activating effects of psychostimulants are mediated by multiple systems. In Drosophila, dopaminergic transmission is involved in mediating the arousing effects of methamphetamine, although the neuronal mechanisms of caffeine (CAFF)-induced wakefulness remain unexplored. Here, we show that in Drosophila, as in mammals, the wake-promoting effect of CAFF involves both the adenosinergic and dopaminergic systems. By measuring behavioral responses in mutant and transgenic flies exposed to different drug-feeding regimens, we show that CAFFinduced wakefulness requires the Drosophila D1 dopamine receptor (dDA1) in the mushroom bodies. In WT flies, CAFF exposure leads to downregulation of dDA1 expression, whereas the transgenic overexpression of dDA1 leads to CAFF resistance. The wakepromoting effects of methamphetamine require a functional dopamine transporter as well as the dDA1, and they engage brain areas in addition to the mushroom bodies.
mutants ͉ sleep ͉ adenosinergic ͉ methamphetamine ͉ mushroom bodies O ptimal behavioral performance in humans and animals depends on an adequate arousal level, which often involves diffuse afferent inputs from the dopaminergic system. Caffeine (CAFF) displays strong arousing properties and is the most consumed psychoactive drug in the world. CAFF competitively inhibits adenosine A1 and A2 receptors, antagonizing the effects of the sleep-promoting neuromodulator adenosine that accumulates during waking (1) . CAFF also leads to increased dopaminergic and glutamatergic transmission in different striatal subcompartments, which has been linked to its activating and reinforcing effects (2) (3) (4) .
Although CAFF-induced wakefulness has been related to modulation of cholinergic and histaminergic arousal systems (5, 6 ), CAFF's induction of increased dopaminergic transmission and its effect on wakefulness have not been adequately examined. Animals with increased dopaminergic transmission, such as dopamine transporter (DAT) mutant mice, have decreased non-rapid eye movement sleep and increased sensitivity to the wake-promoting action of CAFF (7) . Dopaminergic action on both the D1 and D2 receptors contributes to the alert waking state, based on the action of centrally administered D1 and D2 agonists in rodents (8) . Molecularly, CAFF modulates D2 transcription in vitro and in vivo (9) . Motor-activating effects of CAFF are diminished in D2R mutant mice (10, 11) ; however, the role of D2R in the arousing effect of CAFF remains unknown, and functional tests of the brain regions mediating these effects are lacking in mammals.
We have shown previously that the wake-promoting effects of methamphetamine (METH) in Drosophila are mediated through dopaminergic transmission, indicating some evolutionary conservation in the behavioral and neurochemical effects of psychostimulants (12) .
Treatment of flies with CAFF induces wakefulness; however, the mechanism underlying this activity is currently unknown (13, 14) . In the present study, we investigate the role of dopamine signaling in the wake-inducing properties of CAFF and METH, with emphasis on the role of the Drosophila D1 dopamine receptor (dDA1) and the DAT. We show that the wakepromoting action of CAFF engages both adenosine and dopamine receptors and that CAFF leads to modulation of D1-like receptors. Wake-promoting actions of CAFF, in particular, require an area of the fly brain that has been linked to both sleep regulation and learning and memory, namely, the mushroom bodies (MBs). Our findings emphasize the conservation of neural mechanisms regulating the wake-promoting actions of psychostimulants between mammals and invertebrates and provide a model for the neural and molecular basis of behaviors modulated by arousal.
Results

Adenosinergic and Dopaminergic Systems Mediate Wake-Promoting
Effects of CAFF in Drosophila. In Drosophila, CAFF, an adenosine receptor antagonist, decreases sleep and cycloxyladenosine, a specific A1 receptor agonist, promotes sleep; however, the neural mechanism for this action is not known (13, 14) . We exposed WT flies to increasing concentrations of CAFF administered through regular fly food either (i) during a 12-h period of lights off short-term exposure (STE) or (ii) continuously during a 96-h period of long-term exposure (LTE). Both STE and LTE reduced sleep dose dependently, mirrored by a dosedependent increase in locomotor activity, indicating CAFF's arousing and motor-activating effects in Drosophila [ Fig. 1A and supporting information (SI) Fig. S1 A] . Although CAFF significantly increases activity, such activity remains lower than the activity of unexposed active flies during the day (Fig. S1 A) , similar to that of METH-exposed WT flies (Fig. S1B) . CAFFinduced sleep loss is mimicked by the specific A1 (Adenosine 1) receptor antagonist, 8-Cyclopentyll-1,3-dimethlxanthin (CPT) and the A2 (Adenosine 2) receptor antagonist, 3,7-Dimethyl-1-2-propynylxanthine (Fig. 1B) . Because both specific and nonspecific adenosine antagonists led to similar behavioral consequences, this suggests that the wake-promoting effects of CAFF are mediated by adenosine receptors. Because a single adenosine receptor (AdoR), a likely counterpart of the A2B receptor in mammals, has been described in Drosophila (15) , the arousing effects of adenosine receptor antagonists and CAFF are most likely mediated by the same AdoR.
D1-like receptors in mammals mediate the wake-promoting and motor-activating properties of psychostimulants such as cocaine and amphetamines (8, (16) (17) (18) . CAFF leads to increased dopaminergic transmission by antagonizing A1 receptors on presynaptic dopaminergic neurons (19) . To determine if dDA1 mediates the arousing effects of CAFF, we measured sleep in the CAFF-exposed dDA1 mutant dumb 1 (20) . The dumb 1 mutants showed pronounced resistance to the wake-promoting effect of CAFF and lost a small amount of sleep only at the highest CAFF doses (see Fig. 2A and Fig. S2 for additional details). The behavioral consequences of CAFF exposure were similar during STE and LTE ( Fig. 2 A and B) , indicating that the mutant's resistance cannot be overcome by long-term cumulative effects of the drug. We also observed that lethality in dumb 1 flies caused by LTE occurred at the same concentrations as in WT flies, that is, at concentrations higher than 1 mg/ml (Figs. 1 A and 2B ). Similar mortality in WT and dumb 1 flies, but distinct wakepromoting effects, suggest that the wake-promoting effects occur via a different mechanism.
To determine if increased dopaminergic signaling influences CAFF responsiveness, we measured the amount of sleep in CAFF-exposed DAT mutant flies, fumin ( fmn) (21) . Increased dopaminergic signaling in fmn leads to increased arousal (less sleep) and hyperactivity, as in DAT mutant mice (21) (22) (23) . Compared with WT flies, fmn flies show significant sleep loss and a trend toward greater sensitivity at lower concentrations of CAFF. At 0.25 mg/ml, fmn lost 18.4 Ϯ 6.5% (P Ͻ 0.05 compared with their baseline) versus WT loss of 11.1 Ϯ 5.6% (P Ͼ 0.05 compared with their baseline); at 0.5 mg/ml, fmn lost 31.5 Ϯ 5.4% versus WT loss of 24.1 Ϯ 2.9% (both P Ͻ 0.05 compared with their respective baselines). At high concentrations, fmn flies lost more sleep at 2.5 mg/ml (40.1 Ϯ 10%) than at 5 mg/ml CAFF (27.3 Ϯ 5%) (Figs. 1 A and 2 A) . This was likely attributable to a motor depressant effect of high CAFF dose in fmn flies, because high doses commonly suppress motor activity (24) . The motor depressant effect of CAFF was evident at lower concentrations than in the WT flies. The fmn flies were also more sensitive to the lethal effects of CAFF, evident as lethality during LTE at doses higher than 0.5 mg/ml (Fig. 2B) .
To determine whether the effectiveness of CAFF in reducing sleep requires a functional dopaminergic system, we exposed dumb 1 and fmn flies to 2.5 mg/ml CPT. As shown in Fig. 2C , treatment of these mutants with CPT mimicked the action of CAFF. The dumb 1 flies were resistant to the wake-promoting effects of CPT, whereas fmn flies lost more sleep than WT flies . LTE values represent average amount of sleep loss during the night, for four nights of the exposure, only for flies that survived until day 4. LTE to CAFF concentrations greater than 1 mg/ml led to lethality. More than 90% of flies survived until day 4 on 1 mg/ml CAFF, similar to the sham-treated group. At 2.5 mg/ml, survival to day 4 was variable (ϳ50% of flies). (B) Specific adenosine receptor antagonists lead to sleep loss in WT flies. Percent change in amount of sleep during the 12 h of lights off on 2.5 mg/ml nonspecific adenosine antagonist CAFF (n ϭ 14), A1R antagonist CPT (n ϭ 16), and A2R antagonist 3,7-Dimethyl-1-2-propynylxanthine (DMPX) (n ϭ 28) compared with baseline night in WT female flies. *Significant difference by Student's t test (P Ͻ 0.05) compared with 0-mg/ml CAFF group. (Canton-S ϭ Ϫ30.5 Ϯ 4.8, fmn ϭ Ϫ48.4 Ϯ 11.3). Resistance to the wake-promoting effects of either the nonspecific adenosine receptor antagonist CAFF or the specific A1 antagonist CPT in dDA1 mutant flies indicates a functional relation between the adenosine and dopamine receptors in mediating the wakepromoting effects of adenosine receptor antagonists. Significant CPT-induced sleep loss in fmn flies further shows that functional DAT is not necessary for the wake-inducing effect of adenosinergic antagonists.
Wake-Promoting Effects of CAFF Involve Modulation of dDA1 Receptor in MBs. To identify brain areas in which the dDA1 receptor mediates the action of CAFF, we expressed a WT copy of dDA1 in the brains of dumb 1 mutant flies, using the UAS/GAL4 binary expression system. We first expressed dDA1 in all the neurons of dumb 1 mutant flies, using the elav promoter. The dDA1/elav; dumb 1 flies showed significant sleep loss at 2.5 mg/ml CAFF, indicating successful rescue of CAFF responsiveness (Fig. 3A) . Control flies that do not express a functional dDA1 receptor, dDA1/ϩ; dumb 1 and elav/ϩ; dumb 1 , remained resistant to CAFF (Fig. 3A) .
In WT flies, dDA1 is strongly expressed in the MBs, where it plays an important role in olfactory associative learning (20) . Therefore, we expressed a functional copy of dDA1 in the MBs of otherwise mutant flies in an attempt to rescue the resistance of dumb 1 flies to CAFF. As shown in Fig. 3A , C747, a MB driver, fully restored the wake-promoting effects of CAFF in dumb 1 mutant flies. The dDA1/C747; dumb 1 flies on CAFF lost 40.7% of their usual amount of sleep, whereas control flies with only one of the two components, DA1/ϩ; dumb 1 or C747/ϩ; dumb 1 , showed no significant sleep loss (Fig. 3A) . We attained similar results using another MB driver, MB247, suggesting a major role for MBs in mediating the wake-promoting effects of CAFF (Fig.  3A) . Expression of dDA1 in the entire brain, using the elav driver, produced greater CAFF-induced sleep loss compared with restricted MB expression (dDA1/elav; dumb 1 ϭ Ϫ56.5 Ϯ 6.5, dDA1/C747; dumb 1 (Fig. S3) 
In mammals, CAFF induces the expression of D2 receptors in vivo and in vitro (9) ; however, it is unknown if the D1 receptor is under similar transcriptional regulation. To determine if changes in expression of dDA1 are correlated with wake-inducing properties of CAFF in Drosophila, we analyzed the expression of dDA1 mRNA in the heads of WT f lies following STE and LTE to CAFF. Samples were collected from f lies that lost more than 30% of their baseline amount of sleep (64.1 Ϯ 2.5% during STE and 50.5 Ϯ 5.7% during LTE) compared with sham-treated f lies that changed their amount of sleep by less than 10%. Fig. 3B (Inset) shows that CAFF led to significant downregulation of dDA1 receptor expression after STE and LTE.
To determine if the downregulation is functionally related to CAFF-induced sleep loss, as opposed to being a consequence of CAFF exposure unrelated to sleep loss, we overexpressed dDA1 in the brains of WT flies with the aim of offsetting the modulation of the dDA1 expression. Fig. 3B shows that transgenic flies with dDA1 overexpressed in the entire brain, dDA1/elav flies, maintained their CAFF sensitivity and displayed loss of sleep. This loss was similar to elav/ϩ and dDA1/ϩ control lines, indicating that dDA1 overexpression in the entire brain does not have a functional consequence for the arousal effect of CAFF. However, flies with dDA1 overexpression restricted to the MBs, dDA1/C747, behaved significantly differently from their control siblings, DA1/ϩ and C747/ϩ. The dDA1/C747 flies were CAFF resistant (Fig. 3B) . Similar results were obtained using another MB driver, MB247 (Fig. 3B) . The possibility that this disparity merely reflects inadequacy of MB expression in the elav GAL4 strain is contradicted by experiments showing full rescue of CAFF sensitivity with, and no rescue without, the MB contribution of elav (Fig. 3A and Fig. S3 ). Thus, absence of a functional dDA1 receptor in MBs, as in dumb 1 mutant flies, or overexpression of the receptor only in the MBs, as in C747/dDA1 transgenic flies, both had the same outcome: resistance to the arousing effects of CAFF. These findings suggest that dDA1 receptor downregulation in the MBs is functionally important for eliciting the arousing effects of CAFF.
METH-Induced Wakefulness Does Not Involve Modulation of dDA1
Receptor. Acute METH exposure in mammals induces wakefulness attributable, in part, to increased dopaminergic signaling (8, 18) . We have shown previously that METH-induced arousal correlates with increased dopaminergic signaling in Drosophila (12) . To determine if the arousing effects of CAFF and METH are mediated by the same receptor and transporter, we exposed 1 and fmn flies to increasing doses of METH. In contrast to WT flies, which lost sleep during the STE and LTE to METH, fmn and dumb 1 flies were resistant (Fig. 4) . This result agrees well with findings from D1R and DAT mutant mice, which are likewise resistant to the psychostimulant effect of cocaine and METH (7, 25) . Extended METH exposure in the fly mutants did not increase METH sensitivity; instead, it tended to increase sleep in fmn flies (Fig. 4B) . A similar sleep-promoting effect of METH has also been observed in DAT mutant mice (7) . Thus, in Drosophila, the arousing effects of METH and CAFF involve partially overlapping components of the dopaminergic system: the dDA1 receptor is involved in the behavioral effects of both drugs, whereas DAT is required only for the arousing effects of METH.
Knowing that the expression of dDA1 in MBs is required for the wake-inducing properties of CAFF, we asked if dDA1 in MBs mediates METH-induced wakefulness. The dumb 1 mutant transgenic flies that expressed dDA1 either in the MBs alone (DA1/ C747; dumb 1 or DA1/MB247; dumb 1 ) or in the entire brain (DA1/elav; dumb 1 ) both showed sleep loss on METH (Fig. 5A ). The amount of sleep lost was similar with either whole-brain or MB expression (DA1/elav; dumb 1 ϭ Ϫ16 Ϯ 6.1% sleep loss and DA1/C747; dumb 1 ϭ Ϫ20.3 Ϯ 2.9% sleep loss), indicating that although the expression of dDA1 in MBs mediates METHinduced wakefulness, the expression of dDA1 in areas outside of the MBs does not have a significant additive effect. Thus, dDA1 expression in MB mediates the arousing effects of METH, although not as completely as it does CAFF (see also Fig. S3 ).
Unlike CAFF, STE to METH did not lead to downregulation of dDA1 transcripts in WT flies (Fig. 5B, Inset) ; thus, we speculated that overexpression of dDA1 in WT flies would not lead to resistance to METH. Indeed, METH-exposed elav/ dDA1, C747/dDA1, and MB247/dDA1 transgenic flies all showed substantial sleep loss similar to or greater than the control strains (Fig. 5B) . This finding suggests that although downregulation of dDA1 in MBs may be required for CAFF-induced wakefulness, METH-induced wakefulness does not involve downregulation of dDA1. Because sleep loss in C747/dDA1 flies is somewhat greater than in elav/dDA1 flies, it is possible that METH-induced wakefulness involves differential regulation of dDA1 expression in different brain areas: more in MBs and less in other brain areas. Such a scenario agrees well with our finding that the dDA1 transcript does not change in the samples extracted from whole heads of METH-exposed flies.
dDA1 Receptor Does Not Regulate Baseline Sleep. Although dDA1 is strongly expressed in MBs, where most genes affecting baseline sleep in Drosophila are expressed (26) (27) (28) (29) (30) (31) , the average amount of sleep and activity during waking were indistinguishable between WT and dumb 1 flies (Fig. S4 A and B) , in contrast to fmn flies, which have lowered baseline amounts of sleep and increased locomotor activity during waking (ref. 21 ; Fig. S4 A and  B; see SI Text for additional details.) In Drosophila, the wake-promoting action of the adenosinergic antagonist CAFF is mediated through the dDA1 receptor. Genetic manipulations of the dDA1 receptor, as in dumb 1 mutants, or overexpression of dDA1 in the MBs of transgenic flies both lead to resistance to the arousing effects of CAFF. These apparently paradoxical findings can be reconciled if the CAFF response requires downregulation of the dDA1 receptor in the MBs within a certain range. In support of this model (Fig.  S5) , the dDA1 mRNA transcript in WT flies is downregulated in response to either STE or LTE to CAFF (see Results), the dDA1 product is already reduced to a negligible level in the MBs (and most other regions) of the dumb mutant (20) , and excess expression of the dDA1 receptor in the MBs produces CAFF resistance (see Results), suggesting that levels in these flies cannot be sufficiently downregulated.
A role for the MBs in the control of arousal has been proposed in the past (32) . MBs have an inhibitory effect on locomotor activity but a stimulatory effect toward sleep (33, 34) . Genetic and transgenic manipulations of MBs, which lead to decreasing amounts of sleep, are often accompanied by a shortening of sleep episodes, and can thus be explained by a premature arousing signal (21, 26, 29, 31, 33, 34) .
Our observation that the doses of CAFF that decrease sleep also increase motor activity is similar to the effect of CAFF in vertebrates. In mammals, the antagonistic effect of CAFF on adenosine receptors located on dopaminergic neurons leads to increased release (2, 3, 19) . A similar mechanism might be operating in flies, based on the correlation that we have shown between CAFF responsiveness and functional dDA1 receptors in MBs as well as on the motor-activating effects of dopamine (21) .
Although CAFF and METH lead to similar wake-promoting and motor-activating effects, the neuronal mechanisms underlying responses to these drugs are only partially overlapping. Both responses require a functional dDA1 receptor, particularly in the MBs, but METH does not lead to uniform downregulation of dDA1 in the brain, although it is conceivable that downregulation might occur in a limited area of the brain outside of the MB. Although CAFF-induced wakefulness involves dDA1 downregulation in MBs, METH-induced wakefulness could involve a selective increase of dDA1 in MBs, whereas dDA1 expression might be unchanged or even decreased in other brain areas. Such an interpretation is supported by the lack of significant modulation of dDA1 transcript in samples obtained from the entire brain of METH-fed flies as well as weaker rescue of METH response when dDA1 was expressed in the entire brain vs. the MBs (Fig. 5A) . When dDA1 expression is restricted only to areas outside of the MBs (Fig. S3) , METH response is at least as great as in panneural (elav) expression, further suggesting the possibility of antagonism between MBs and other areas for this effect. Another DA receptor, damb, which is specific to the MBs (35), is not relevant to these responses. It does not show altered regulation in response to CAFF or METH in WT or dumb mutants, and dDA1 expression alone or in combination with CAFF or METH is not altered in damb mutants (R.A., Y.-C.K., K.-A.H., R.J.G., unpublished data).
Altogether, these findings suggest a model in which the arousing and motor-activating effects of CAFF are a consequence of its neuromodulatory action on dopaminergic signaling (Fig. S5) . This is based on similar behavioral responses to CAFF and CPT in Drosophila, which implies that the arousing properties of CAFF involve close interaction between the adenosine and dopamine systems, as they do in mammals. Presynaptically, CAFF can increase dopamine release by antagonizing adenosine receptors on dopaminergic neurons (2, 3) . Resistance to the wake-promoting effect of the A1R antagonist in dumb 1 mutants and decreased expression of dDA1 in WT flies after CAFF exposure support a model in which the adenosinergic system acts as a neuromodulator of dopaminergic signaling. CAFF acting through AdoR on dopaminergic neurons could stimulate dopamine synthesis or release through protein kinase A dependent mechanisms similar to the A2A receptor in mammals (4) . Postsynaptically, dDA1 receptors located on MB neurons respond homeostatically by downregulating their expression, a common adaptive mechanism in response to excessive stimulation. A related mechanism involving A1-D1 receptor interaction was observed in the rodent brain and implicated in the psychostimulant properties of CAFF (36) . Furthermore, a recent Drosophila report shows increased dopaminergic content concomitant with decreased dDA1 expression in the brains of sleepdeprived flies (37) . (26, 27, 29, 30, 31, 33, 34) . Our findings show that dDA1, a receptor with a role in neuronal plasticity in MB-dependent learning tasks, has only a moderate role in regulation of baseline sleep, although it is important in conditions of elevated arousal, such as those induced by stimulants.
Role of MBs in
Optimal behavioral performance, such as learning, is dependent on adequate levels of arousal (39, 40) . Although psychostimulant exposure increases dopaminergic transmission and increases general arousal, it also influences specific functions related to reward (40) . These multiple roles are preserved in Drosophila, in which mechanisms for arousal and learning converge on the dDA1 receptor, thus ensuring that learning associated with survival occurs in an attentive and awake organism. CAFF and METH effects on dDA1 receptors in MBs could be mimicking, albeit at an elevated level, the increased dopaminergic signaling that otherwise occurs during learning and memory, reflecting the role that dDA1 receptors play in that process.
Methods
Animals. Flies were housed at 25°C, 60% humidity, and a 12-h light/dark cycle on standard agar-and yeast-based food (12) . Canton-S was our standard background for all strains: dumb 1 , fmn, UAS-dDA1; dumb 1 /TM3, Tb, C747; dumb 1 , elavGAL4/CyO; dumb 1 , MB247/CyO; and dumb 1 , UAS-dDA1, and elavGal4, C747.
Sleep Measurements. Sleep was measured using the Drosophila Activity Monitoring System (TriKinetics), with a data collection interval set at 5 min as described previously (41), with ad libitum food.
Pharmacological Treatment. Flies were exposed to CAFF or METH during 12 h of lights off or for 96 h starting at lights on. Water-based solutions of drugs were mixed into the food. Drug effects during STE were calculated by comparing the amount of sleep during the baseline night (without drug) with that during the treatment night. The ''sham'' control for manipulation was a group of flies transferred to food without drug.
Quantitative PCR. Total RNA extraction, reverse transcription, and quadruplicate RT-quantitative PCR assays were performed as described elsewhere (28) . Primers were as follows: dumb forward 5Ј-CCGTCGTGTCCAGCTGTA-3Ј and reverse 5ЈATAGCAGTATAGCCGACAGTAGATG-3Ј and RP49 forward 5Ј-TGGAGGTCCTGCTCATGCA-3Ј and reverse 5Ј-GGCATCTCGCGCAGTAAAC-3Ј.
